Sec Form 3 Filing - 11.2 Capital I Partners, LLC @ Hinge Health, Inc. - 2025-05-21

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person 11.2 Capital I Partners, LLC 2. Issuer Name and Ticker or Trading Symbol Hinge Health, Inc. [ HNGE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 1611 SPRING GATE LN, UNIT 371763 3. Date of Earliest Transaction (MM/DD/YY) 05/21/2025 (Street) LAS VEGAS, NV89134 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series S-1 Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 1,455,604 I See footnote ( 2 ) ( 3 ) Series A-1 Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 230,923 I See footnote ( 2 ) ( 3 ) Series A-2 Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 1,932,367 I See footnote ( 2 ) ( 3 ) Series C Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 1,230,364 I See footnote ( 2 ) ( 4 ) Series D Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 251,606 I See footnote ( 2 ) ( 5 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other 11.2 Capital I Partners, LLC 1611 SPRING GATE LN, UNIT 371763 LAS VEGAS, NV89134 X 11.2 Capital I, L.P. 1611 SPRING GATE LN, UNIT 371763 LAS VEGAS, NV89134 X 11.2 Capital Ivy Partners, LLC 1611 SPRING GATE LN, UNIT 371763 LAS VEGAS, NV89134 X 11.2 Capital HH, LLC 1611 SPRING GATE LN, UNIT 371763 LAS VEGAS, NV89134 X 11.2 Capital Ivy, LLC 1611 SPRING GATE LN, UNIT 371763 LAS VEGAS, NV89134 X Zhuang Qian 1611 SPRING GATE LN, UNIT 371763 LAS VEGAS, NV89134 X Signatures 11.2 Capital I Partners, LLC, By: /s/ Shelley Zhuang 05/21/2025 Signature of Reporting Person Date 11.2 Capital I, L.P., By: /s/ Shelley Zhuang 05/21/2025 Signature of Reporting Person Date 11.2 Capital Ivy Partners, LLC, By: /s/ Shelley Zhuang 05/21/2025 Signature of Reporting Person Date 11.2 Capital HH, LLC, By: /s/ Shelley Zhuang 05/21/2025 Signature of Reporting Person Date 11.2 Capital IVY, LLC, By: /s/ Shelley Zhuang 05/21/2025 Signature of Reporting Person Date /s/ Shelley Zhuang 05/21/2025 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, will automatically convert and be reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. ( 2 )11.2 Capital I Partners, LLC is the general partner of 11.2 Capital I, L.P. ("11.2 Capital I") and 11.2 Capital Ivy Partners, LLC is the general partner of each of 11.2 Capital HH, LLC ("11.2 Capital HH") and 11.2 Capital IVY, LLC ("11.2 Capital IVY" and together with 11.2 Capital HH and 11.2 Capital I, the "11.2 Capital Entities")). Shelley Zhuang is the sole managing member of each of 11.2 Capital I Partners, LLC and 11.2 Capital Ivy Partners, LLC. As a result, each of the foregoing may be deemed to share beneficial ownership of the securities held by the 11.2 Capital Entities. ( 3 )Securities held of record by 11.2 Capital I. ( 4 )Consists of (i) 205,060 shares held by 11.2 Capital I and (ii) 1,025,304 shares held by 11.2 Capital IVY. ( 5 )Consists of (i) 171,550 shares held by 11.2 Capital HH and (ii) 80,056 shares held by 11.2 Capital IVY.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.